|
|
Exploristics
| Need to make the most of your data? |
|
At Exploristics we provide innovative analysis solutions to maximise the information derived from your clinical data. We offer unique expertise in the exploratory analysis, design and clinical application of Biomarkers, Pharmacogenomics, Imaging and Observational data as well as advanced modeling of complex systems.
The team at Exploristics offers more than a statistical analysis and reporting service. We take pride in using our analytical skills and scientific expertise to help you make informed decisions. We work closely with our customers to understand their data analysis needs and to provide practical solutions. So far, we have worked successfully with Pharmaceutical, Biotechnology, Medical Diagnostics and Devices Companies as well as Healthcare providers. Our service is friendly and cost-effective and our work is compliant with GCP/ICH guidelines.
Join our expanding group of satisfied clients and contact us today!
|
|
|
|
|
|
Opportunities for Pharmacogenetics
Drug Regulators are now requesting the collection of blood samples for Pharmacogenetics research as part of clinical development programs. We work with customers to help them discover and exploit the PGx opportunities within their development portfolio.
|
Our services are tailored to address your specific needs.
» Consultancy
» Data Exploration
» Experimental Design
» Modeling and Simulation
» In-licensing opportunities
» Pharmacogenomics
» Biomarker Analysis
» Predictive Modeling
» Training and Education
We are keen to discuss your specific requirements so please give Exploristics a call to find out how we can support your business.
|
|
Drug Supply Logistics / Patient Recruitment
Exploristics offers a suite of innovative predictive modelling modules for use in the design and implementation of clinical trials. These modules can optimise drug supply and patient recruitment by reducing supply overage and recruitment times.
|
|
Evaluating surrogate endpoints
There is increasing interest in the Pharmaceutical industry to find other more sensitive endpoints than those accepted currently by regulators. We have helped to design and analyse studies into imaging modalities to compare new endpoints with traditional measures.
|
|
Analysis of QoL and PRO data
Quality of Life, Patient Reported Outcomes, Clinical Ratings Scales and Composite Endpoints have important applications in clinical research and practice. These instruments provide vital measures of the effectiveness of treatment as well as the general well-being and physical and psychological state of the patient.
|
|
|